In response to increasing anti-vaccination sentiment and concerns regarding the new polio vaccine introduced in March 2021, the Expanded Program on Immunization (EPI) has launched a routine communication campaign. This campaign aims to educate parents and promote the importance of routine polio vaccination as part of the EPI program, which provides five doses at specific intervals starting from birth.
The EPI emphasizes that this communication is not a response to a new polio outbreak, but an ongoing effort to improve vaccination coverage and address vaccine hesitancy. The video message, subtitled for accessibility, clarifies the safety and effectiveness of the new oral polio vaccine type 2, developed to combat the circulating variant of the virus.
“To reduce and end epidemics due to the circulating poliovirus type 2 variant, scientists have developed the new oral polio vaccine type 2. The vaccine, developed in 2011, is safe,” the video indicates.
This awareness campaign comes amidst broader public concerns surrounding new vaccines. Notably, the arrival of over 330,000 doses of malaria vaccine last November sparked heated debate, leading health authorities to reiterate its approval by the World Health Organization (WHO).
Michel Ange Nga